NEW YORK—Mid-August saw LifeSci Partners announce the launch of its newest division, LifeSci Strategic Partnering and Analytics, which is focused on supporting partnering and strategic consulting activities for clients exclusively within the life sciences.
The strategic partnering activities include facilitating in-licensing and out-licensing transactions and research and development collaborations, among other types of partnerships. As for the analytics part of the division, that offering will deliver primary and secondary market research and financial analyses to assist companies in understanding and effectively articulating asset value propositions to investors and strategic partners, and will guide internal development and capital allocation decisions.
The addition of the new division adds strategic partnering and market analytics to such previous offerings as investor relations, public relations, corporate communications, capital markets consulting and executive searches.
“LifeSci Partners continues to leverage its extensive relationships and unmatched domain expertise within the life sciences on behalf of our clients ... our newest division will address our clients’ strategic partnering needs, harnessing our extensive network of global relationships with senior executives and business development professionals at large and midsize life science companies,” said Dr. Andrew McDonald, co-founder of LifeSci Partners. “We recognize it is crucial for companies to properly assess the commercial potential and value proposition of their assets to support financing, partnering and internal decision-making activities. LifeSci Strategic Partnering and Analytics utilizes LifeSci’s expertise in financial modeling, physician surveys and KOL [key opinion leader] interviews to help companies define their market opportunity based on hard data, increasing the likelihood of attracting and securing resources necessary to bring novel technologies to market.”
